{"id":19599,"date":"2025-03-20T06:00:53","date_gmt":"2025-03-20T06:00:53","guid":{"rendered":"https:\/\/interhospi.com\/?p=19599"},"modified":"2025-03-17T12:05:11","modified_gmt":"2025-03-17T12:05:11","slug":"varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems","status":"publish","type":"post","link":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/","title":{"rendered":"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems"},"content":{"rendered":"<div id='av_section_1'  class='avia-section main_color avia-section-default avia-no-border-styling  avia-bg-style-scroll  avia-builder-el-0  avia-builder-el-no-sibling   container_wrap fullsize' style=' '  ><div class='container' ><main  role=\"main\" itemprop=\"mainContentOfPage\"  class='template-page content  av-content-full alpha units'><div class='post-entry post-entry-type-page post-entry-19599'><div class='entry-content-wrapper clearfix'>\n<div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding first  avia-builder-el-1  el_before_av_three_fifth  avia-builder-el-first  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><\/div><div class=\"flex_column av_three_fifth  flex_column_div av-zero-column-padding   avia-builder-el-3  el_after_av_one_fifth  el_before_av_one_fifth  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><header class=\"entry-content-header\"><h1 class=\"post-title entry-title\" itemprop=\"headline\">Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems<\/h1><span class=\"post-meta-infos\">\/ <span class=\"blog-categories minor-meta\">in <a href=\"https:\/\/interhospi.com\/category\/product-news\/\" rel=\"tag\">Product News<\/a>  <\/span><\/span><\/header>\n<\/div><\/section><br \/>\n<section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p><strong>Varian, a Siemens Healthineers company, has received FDA 510(k) clearance for its HyperSight imaging solution on TrueBeam and Edge radiotherapy systems. This technology enables high-quality adaptive radiotherapy planning with reduced imaging times and improved anatomical accuracy, potentially enhancing treatment precision and patient comfort.<\/strong><\/p>\n<p><!--more--><\/p>\n<h3><img decoding=\"async\" class=\"alignnone size-full wp-image-19600\" src=\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg\" alt=\"Varian HyperSight imaging solution \" width=\"783\" height=\"435\" srcset=\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg 783w, https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian-300x167.jpg 300w, https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian-768x427.jpg 768w, https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian-705x392.jpg 705w\" sizes=\"(max-width: 783px) 100vw, 783px\" \/><\/h3>\n<h3><strong>Advanced imaging capabilities expand across treatment platforms<\/strong><\/h3>\n<p>The HyperSight imaging solution, originally launched in 2022 on Varian\u2019s Ethos and Halcyon therapy systems, has now been extended to the company\u2019s TrueBeam and Edge radiotherapy systems. This expansion represents a significant advancement in imaging technology available within the radiotherapy treatment room.<\/p>\n<p>HyperSight enables clinicians to acquire high-quality cone-beam CT (CBCT) images during a patient\u2019s daily radiation treatments. These images deliver Hounsfield Unit (HU) accuracy comparable to conventional CT scanners, making them suitable for treatment planning directly from the acquired CBCT images. This capability eliminates the need for patients to make additional trips to a separate CT scanner when anatomical adaptations are required.<\/p>\n<h3><strong>Faster acquisition with improved clinical outcomes<\/strong><\/h3>\n<p>A notable technical improvement with HyperSight on TrueBeam and Edge systems is the 50% faster gantry rotation, which significantly reduces image acquisition time compared to traditional CBCT scans that can take up to 60 seconds. This speed enhancement offers several clinical benefits:<\/p>\n<ul>\n<li>Reduced motion-related artifacts due to minimised patient movement<\/li>\n<li>Decreased patient discomfort and anxiety through shorter time on the treatment table<\/li>\n<li>Greater precision in targeting tumour volumes whilst sparing healthy tissue<\/li>\n<\/ul>\n<p>Dr Wesley Talcott, Assistant Professor and Radiation Oncologist at Lenox Hill Hospital\u2019s Cancer Institute, an early adopter of HyperSight on their Halcyon system, reported: \u201cHyperSight imaging has allowed us to improve patient comfort by decreasing the time patients spend on the treatment table while simultaneously targeting with greater confidence.\u201d<\/p>\n<h3><strong>Research collaboration and clinical evidence<\/strong><\/h3>\n<p>Varian has demonstrated commitment to evidence-based implementation of HyperSight through clinical research partnerships. Nine studies have been conducted, are in progress, or are planned across eight institutions to better understand the technology\u2019s role in advancing care and enhancing patient experience.<\/p>\n<p>The company has also established an Intelligent Imaging Consortium, providing HyperSight users with a collaborative forum to innovate on trials and studies, potentially accelerating clinical implementation and optimisation.<\/p>\n<h3><strong>Integration within comprehensive cancer care<\/strong><\/h3>\n<p>Arthur Kaindl, Head of Varian, emphasised the company\u2019s strategic direction: \u201cAs a Siemens Healthineers company, we are pioneering innovative solutions to advance radiotherapy and connect the power of imaging, both inside and outside the treatment room.\u201d<\/p>\n<p>This integration of advanced imaging across Varian\u2019s radiotherapy platforms aligns with broader trends in precision medicine and personalised cancer care. By improving the accuracy of treatment delivery and streamlining clinical workflows, HyperSight technology may contribute to better patient outcomes whilst potentially improving operational efficiency in radiotherapy departments.<\/p>\n<ul>\n<li>For more information, visit: <a href=\"http:\/\/www.varian.com\/hypersight\" target=\"_blank\" rel=\"noopener\">varian.com\/hypersight<\/a><\/li>\n<\/ul>\n<\/div><\/section><br \/>\n<div  style='height:50px' class='hr hr-invisible   avia-builder-el-7  el_after_av_textblock  el_before_av_social_share '><span class='hr-inner ' ><span class='hr-inner-style'><\/span><\/span><\/div><br \/>\n<div  class='av-social-sharing-box  avia-builder-el-8  el_after_av_hr  avia-builder-el-last  av-social-sharing-box-minimal '><div class='av-share-box'><h5 class='av-share-link-description av-no-toc '>Share this<\/h5><ul class='av-share-box-list noLightbox'><li class='av-share-link av-social-link-facebook' ><a target=\"_blank\" aria-label=\"Share on Facebook\" href='https:\/\/www.facebook.com\/sharer.php?u=https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/&#038;t=Varian%20receives%20FDA%20clearance%20for%20enhanced%20imaging%20technology%20across%20radiotherapy%20systems' aria-hidden='false' data-av_icon='\ue8f3' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on Facebook' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Facebook<\/span><\/a><\/li><li class='av-share-link av-social-link-twitter' ><a target=\"_blank\" aria-label=\"Share on Twitter\" href='https:\/\/twitter.com\/share?text=Varian%20receives%20FDA%20clearance%20for%20enhanced%20imaging%20technology%20across%20radiotherapy%20systems&#038;url=https:\/\/interhospi.com\/?p=19599' aria-hidden='false' data-av_icon='\ue8f1' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on Twitter' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on Twitter<\/span><\/a><\/li><li class='av-share-link av-social-link-whatsapp' ><a target=\"_blank\" aria-label=\"Share on WhatsApp\" href='https:\/\/api.whatsapp.com\/send?text=https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/' aria-hidden='false' data-av_icon='\uf232' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on WhatsApp' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on WhatsApp<\/span><\/a><\/li><li class='av-share-link av-social-link-linkedin' ><a target=\"_blank\" aria-label=\"Share on LinkedIn\" href='https:\/\/linkedin.com\/shareArticle?mini=true&#038;title=Varian%20receives%20FDA%20clearance%20for%20enhanced%20imaging%20technology%20across%20radiotherapy%20systems&#038;url=https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/' aria-hidden='false' data-av_icon='\ue8fc' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share on LinkedIn' rel=\"noopener\"><span class='avia_hidden_link_text'>Share on LinkedIn<\/span><\/a><\/li><li class='av-share-link av-social-link-mail' ><a  aria-label=\"Share by Mail\" href='mailto:?subject=Varian%20receives%20FDA%20clearance%20for%20enhanced%20imaging%20technology%20across%20radiotherapy%20systems&#038;body=https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/' aria-hidden='false' data-av_icon='\ue805' data-av_iconfont='entypo-fontello' title='' data-avia-related-tooltip='Share by Mail'><span class='avia_hidden_link_text'>Share by Mail<\/span><\/a><\/li><\/ul><\/div><\/div><\/p><\/div><div class=\"flex_column av_one_fifth  av-hide-on-mobile  flex_column_div av-zero-column-padding   avia-builder-el-9  el_after_av_three_fifth  avia-builder-el-last  \" style='border-radius:0px; '><section class=\"av_textblock_section \"  itemscope=\"itemscope\" itemtype=\"https:\/\/schema.org\/BlogPosting\" itemprop=\"blogPost\" ><div class='avia_textblock  '   itemprop=\"text\" ><p style=\"text-align: center\"><\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Varian, a Siemens Healthineers company, has received FDA 510(k) clearance for its HyperSight imaging solution on TrueBeam and Edge radiotherapy systems. This technology enables high-quality adaptive radiotherapy planning with reduced imaging times and improved anatomical accuracy, potentially enhancing treatment precision and patient comfort.<\/p>\n","protected":false},"author":3,"featured_media":19600,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[6],"tags":[],"class_list":["post-19599","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems - International Hospital<\/title>\n<meta name=\"description\" content=\"Varian receives FDA 510(k) clearance for HyperSight imaging on TrueBeam and Edge radiotherapy systems, enabling faster, more precise adaptive treatment planning.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems - International Hospital\" \/>\n<meta property=\"og:description\" content=\"Varian receives FDA 510(k) clearance for HyperSight imaging on TrueBeam and Edge radiotherapy systems, enabling faster, more precise adaptive treatment planning.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\" \/>\n<meta property=\"og:site_name\" content=\"International Hospital\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-20T06:00:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"783\" \/>\n\t<meta property=\"og:image:height\" content=\"435\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"panglobal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"panglobal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\"},\"author\":{\"name\":\"panglobal\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1\"},\"headline\":\"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems\",\"datePublished\":\"2025-03-20T06:00:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\"},\"wordCount\":1033,\"publisher\":{\"@id\":\"https:\/\/interhospi.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg\",\"articleSection\":[\"Product News\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\",\"url\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\",\"name\":\"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems - International Hospital\",\"isPartOf\":{\"@id\":\"https:\/\/interhospi.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg\",\"datePublished\":\"2025-03-20T06:00:53+00:00\",\"description\":\"Varian receives FDA 510(k) clearance for HyperSight imaging on TrueBeam and Edge radiotherapy systems, enabling faster, more precise adaptive treatment planning.\",\"breadcrumb\":{\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage\",\"url\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg\",\"contentUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg\",\"width\":783,\"height\":435,\"caption\":\"Varian HyperSight imaging solution\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/interhospi.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/interhospi.com\/#website\",\"url\":\"https:\/\/interhospi.com\/\",\"name\":\"International Hospital\",\"description\":\"The medical device information portal connecting healthcare professionals to global vendors\",\"publisher\":{\"@id\":\"https:\/\/interhospi.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/interhospi.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/interhospi.com\/#organization\",\"name\":\"International Hospital\",\"url\":\"https:\/\/interhospi.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg\",\"contentUrl\":\"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg\",\"width\":652,\"height\":188,\"caption\":\"International Hospital\"},\"image\":{\"@id\":\"https:\/\/interhospi.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1\",\"name\":\"panglobal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/interhospi.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g\",\"caption\":\"panglobal\"},\"url\":\"https:\/\/interhospi.com\/author\/panglobal\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems - International Hospital","description":"Varian receives FDA 510(k) clearance for HyperSight imaging on TrueBeam and Edge radiotherapy systems, enabling faster, more precise adaptive treatment planning.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/","og_locale":"en_GB","og_type":"article","og_title":"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems - International Hospital","og_description":"Varian receives FDA 510(k) clearance for HyperSight imaging on TrueBeam and Edge radiotherapy systems, enabling faster, more precise adaptive treatment planning.","og_url":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/","og_site_name":"International Hospital","article_published_time":"2025-03-20T06:00:53+00:00","og_image":[{"width":783,"height":435,"url":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg","type":"image\/jpeg"}],"author":"panglobal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"panglobal","Estimated reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#article","isPartOf":{"@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/"},"author":{"name":"panglobal","@id":"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1"},"headline":"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems","datePublished":"2025-03-20T06:00:53+00:00","mainEntityOfPage":{"@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/"},"wordCount":1033,"publisher":{"@id":"https:\/\/interhospi.com\/#organization"},"image":{"@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage"},"thumbnailUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg","articleSection":["Product News"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/","url":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/","name":"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems - International Hospital","isPartOf":{"@id":"https:\/\/interhospi.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage"},"image":{"@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage"},"thumbnailUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg","datePublished":"2025-03-20T06:00:53+00:00","description":"Varian receives FDA 510(k) clearance for HyperSight imaging on TrueBeam and Edge radiotherapy systems, enabling faster, more precise adaptive treatment planning.","breadcrumb":{"@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#primaryimage","url":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg","contentUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/03\/varian.jpg","width":783,"height":435,"caption":"Varian HyperSight imaging solution"},{"@type":"BreadcrumbList","@id":"https:\/\/interhospi.com\/varian-receives-fda-clearance-for-enhanced-imaging-technology-across-radiotherapy-systems\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/interhospi.com\/"},{"@type":"ListItem","position":2,"name":"Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems"}]},{"@type":"WebSite","@id":"https:\/\/interhospi.com\/#website","url":"https:\/\/interhospi.com\/","name":"International Hospital","description":"The medical device information portal connecting healthcare professionals to global vendors","publisher":{"@id":"https:\/\/interhospi.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/interhospi.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/interhospi.com\/#organization","name":"International Hospital","url":"https:\/\/interhospi.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/interhospi.com\/#\/schema\/logo\/image\/","url":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg","contentUrl":"https:\/\/interhospi.com\/wp-content\/uploads\/sites\/3\/2025\/01\/IH-logo.jpg","width":652,"height":188,"caption":"International Hospital"},"image":{"@id":"https:\/\/interhospi.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/interhospi.com\/#\/schema\/person\/4689adfa1bdc4ca8bd2efdb65d94fac1","name":"panglobal","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/interhospi.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/44754a569744e74e7138c83d1888f5c0?s=96&d=mm&r=g","caption":"panglobal"},"url":"https:\/\/interhospi.com\/author\/panglobal\/"}]}},"_links":{"self":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/19599","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/comments?post=19599"}],"version-history":[{"count":1,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/19599\/revisions"}],"predecessor-version":[{"id":19601,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/posts\/19599\/revisions\/19601"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/media\/19600"}],"wp:attachment":[{"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/media?parent=19599"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/categories?post=19599"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/interhospi.com\/wp-json\/wp\/v2\/tags?post=19599"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}